إعلان
إعلان
KPRX
Kiora Pharmaceuticals, Inc. Common Stock
2.16
USDبرعاية
-0.03
-1.33%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.13
-0.02
-0.97%
تقارير أرباح KPRX
النسبة الإيجابية المفاجئة
KPRX تفوق 24 من 38 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.53M
/-$0.68
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-6900.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-34.62%
Kiora Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, KPRX reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.74 USD, resulting in a 101.33% surprise. Revenue reached --, compared to an expected 765.00 ألف, with a -100.00% difference. The market reacted with a +0.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.68 USD, with revenue projected to reach 1.53 مليون USD, implying an نقصان of -6900.00% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Kiora Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Kiora Pharmaceuticals, Inc. Common Stock reported EPS of $0.01, beating estimates by 101.33%, and revenue of $0.00, -100% below expectations.
How did the market react to Kiora Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.43%, changed from $2.32 before the earnings release to $2.33 the day after.
When is Kiora Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
What are the forecasts for Kiora Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Kiora Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $1.53M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان